Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1

被引:163
作者
Dixon, DA
Balch, GC
Kedersha, N
Anderson, P
Zimmerman, GA
Beauchamp, RD
Prescott, SM
机构
[1] Vanderbilt Univ, Med Ctr, Surg Oncol Res Lab, Dept Surg, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Surg Oncol Res Lab, Dept Canc Biol, Nashville, TN 37232 USA
[3] Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA
[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[5] Brigham & Womens Hosp, Div Rheumatol & Immunol, Boston, MA 02115 USA
关键词
COX-2; cyclooxygenase-2; prostaglandins; TIA-1; AU-rich element;
D O I
10.1084/jem.20030616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cyclooxygenase-2 (COX-2) enzyme catalyzes the rate-limiting step of prostaglandin formation in inflammatory states, and COX-2 overexpression plays a key role in carcinogenesis. To understand the mechanisms regulating COX-2 expression, we examined its posttranscriptional regulation mediated through the AU-rich element (ARE) within the COX-2 mRNA 3'-untranslated region (3'UTR). RNA binding studies, performed to identify ARE-binding regulatory factors, demonstrated binding of the translational repressor protein TIA-1 to COX-2 mRNA. The significance of TIA-1-mediated regulation of COX-2 expression was observed in TIA-1 null fibroblasts that produced significantly more COX-2 protein than wild-type fibroblasts. However, TIA-1 deficiency did not alter COX-2 transcription or mRNA turnover. Colon cancer cells demonstrated to overexpress COX-2 through increased polysome association with COX-2 mRNA also showed defective TIA-1 binding both in vitro and in vivo. These findings implicate that TIA-1 functions as a translational silencer of COX-2 expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 21 条
[1]  
Anderson P, 2002, J CELL SCI, V115, P3227
[2]   Misregulated posttranscriptional checkpoints: Inflammation and tumorigenesis [J].
Brewer, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :F1-F4
[3]  
CHEN CYA, 1995, MOL CELL BIOL, V15, P5777
[4]   Post-transcriptional control of cyclooxygenase-2 gene expression -: The role of the 3′-untranslated region [J].
Dixon, DA ;
Kaplan, CD ;
McIntyre, TM ;
Zimmerman, GA ;
Prescott, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :11750-11757
[5]  
Dixon DA, 2003, PROG EXP TUMOR RES, V37, P52
[6]   Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells [J].
Dixon, DA ;
Tolley, ND ;
King, PH ;
Nabors, LB ;
McIntyre, TM ;
Zimmerman, GA ;
Prescott, SM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (11) :1657-1665
[7]   The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing [J].
Förch, P ;
Puig, O ;
Kedersha, N ;
Martínez, C ;
Granneman, S ;
Séraphin, B ;
Anderson, P ;
Valcárcel, J .
MOLECULAR CELL, 2000, 6 (05) :1089-1098
[8]  
Gouble A, 2002, CANCER RES, V62, P1489
[9]   Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 [J].
Gupta, RA ;
DuBois, RN .
NATURE REVIEWS CANCER, 2001, 1 (01) :11-21
[10]  
KAWAKAMI A, 1994, J IMMUNOL, V152, P4937